Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Norepinephrine, also known as noradrenaline, is both a neurotransmitter and a hormone that plays a central role in the body's "fight-or-flight" response. It is involved in vasoconstriction, increasing heart rate, regulating mood, and mobilizing energy stores. Dysregulation of norepinephrine systems is implicated in various conditions, including hypotension, shock, ADHD, depression, and anxiety.
Norepinephrine exerts its effects through binding to adrenergic receptors (alpha1, alpha2, beta1, beta2, beta3), which are G protein-coupled receptors. This binding leads to various downstream effects depending on the receptor subtype, including vasoconstriction, increased heart rate and contractility, smooth muscle relaxation, and lipolysis.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Norepinephrine (NE).